Loading...

Abbott Laboratories (NYSE:ABT)

107.19 USD -1.89 USD ( -1.73% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Section:
 

Wall Street
Price Targets

ABT Price Targets
Price Targets made by Wall Street

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

12-month price targets for ABT stock made by Wall Street professionals. The average price target is 142.08 USD with a low forecast of 112.11 USD and a high forecast of 166.43 USD.

ABT Wall Street Target
Lowest Forecast
112.11 USD
5% Upside
ABT Wall Street Target
Average Forecast
142.08 USD
33% Upside
ABT Wall Street Target
Highest Forecast
166.43 USD
55% Upside
Lowest
Price Target
112.11 USD
5% Upside
Average
Price Target
142.08 USD
33% Upside
Highest
Price Target
166.43 USD
55% Upside
Abbott Laboratories Competitors:
Price Targets
B
BFLY
Butterfly Network Inc
128% Upside
D
7775
Daiken Medical Co Ltd
84% Upside
VREX
Varex Imaging Corp
96% Upside
SONVF
Sonova Holding AG
17% Upside
B
BFLY
Butterfly Network Inc
128% Upside
D
7775
Daiken Medical Co Ltd
84% Upside
VREX
Varex Imaging Corp
96% Upside
SONVF
Sonova Holding AG
17% Upside
ATRC
AtriCure Inc
97% Upside
7779
Cyberdyne Inc
122% Upside
E
ENOV
Enovis Corp
114% Upside
EW
Edwards Lifesciences Corp
32% Upside

Revenue
Forecast

ABT Revenue Forecast
Wall Street Forecast

Abbott Laboratories's Revenue forecast for three years ahead made by Wall Street analysts. Revenue is forecast to grow at a rate of 1% per year.

Year Avg Range
2024
By 17 analysts
44.3B USD
+7%
41.7B - 49.3B USD
2023
By 22 analysts
41.5B USD
-2%
38.9B - 46.1B USD
2022
By 23 analysts
42.2B USD
-2%
40B - 46B USD
CAGR:
Forecast
1%

Operating Income
Forecast

ABT Operating Income Forecast
Wall Street Forecast

Abbott Laboratories's Operating Income forecast for three years ahead made by Wall Street analysts. Operating Income is forecast to grow at a rate of 10% per year.

Year Avg Range
2024
By 16 analysts
11.4B USD
+11%
9.6B - 12.8B USD
2023
By 20 analysts
10.3B USD
+1%
8.4B - 11.7B USD
2022
By 20 analysts
10.2B USD
+19%
8B - 11.6B USD
CAGR:
Forecast
10%

Net Income
Forecast

ABT Net Income Forecast
Wall Street Forecast

Abbott Laboratories's Net Income forecast for three years ahead made by Wall Street analysts. Net Income is forecast to grow at a rate of 11% per year.

Year Avg Range
2024
By 17 analysts
9.6B USD
+12%
8.7B - 10.6B USD
2023
By 23 analysts
8.6B USD
0%
7.7B - 9.5B USD
2022
By 24 analysts
8.6B USD
+22%
8.1B - 9.6B USD
CAGR:
Forecast
11%

See Also

Summary
ABT Intrinsic Value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Other Stocks
ALPHA SPREAD
Join 16,400 value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Pricing Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2022 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Alpha Spread Unlimited
Full access to our stock valuation platform
AAPL
Apple Inc
Price 137.45 USD
Intrinsic Value 125.96 USD
8% Overvalued
GOOGL
Alphabet Inc
Price 2 240.16 USD
Intrinsic Value 2 343.31 USD
4% Undervalued
META
Meta Platforms Inc
Price 160.68 USD
Intrinsic Value 238.52 USD
33% Undervalued
MSFT
Microsoft Corp
Price 256.48 USD
Intrinsic Value 222.2 USD
13% Overvalued
NFLX
Netflix Inc
Price 179.6 USD
Intrinsic Value 207.5 USD
13% Undervalued
SBUX
Starbucks Corp
Price 76.34 USD
Intrinsic Value 68.97 USD
10% Overvalued
Platform Features:
Platform Features:
Intrinsic Valuation
Relative Valuation
DCF Valuation
Wall St Estimates
Profitability Analysis
Solvency Analysis
Company Financials
Discount Rate Calculator
Create your account
Already have an account? Sign in
By using Alpha Spread you are agreeing to our
Terms of Service and Privacy Policy.